Caxton Associates (UK)’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$475K Sell
1,998
-3,509
-64% -$729K 0.01% 546
2026
Q1
$1.16M Sell
5,507
-635
-10% -$137K 0.03% 344
2025
Q4
$1.26M Buy
+6,142
New +$1.16M 0.02% 302
2025
Q3
Sell
-2,501
Closed -$420K 724
2025
Q2
$420K Buy
+2,501
New +$371K 0.01% 465

Other funds holding CAH

Caxton Associates (UK)'s CAH Position: Q2 2026 in Review

Caxton Associates (UK) reduced its Cardinal Health (CAH) stake by 64% in Q2 2026, selling an estimated $729K and leaving 1,998 shares worth $475K. The position accounts for 0.01% of the portfolio, ranked #546.

Caxton Associates (UK) first reported a position in CAH in Q2 2025 and has held it in 4 quarters since. The position peaked at $1.26M in Q4 2025. 1,496 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Caxton Associates (UK) held 1,998 shares of Cardinal Health worth $475K as of Q2 2026.
  • Caxton Associates (UK) sold 3,509 Cardinal Health shares in Q2 2026, an estimated $729K.
  • Cardinal Health made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #546 holding.
  • Caxton Associates (UK) first reported a position in Cardinal Health in Q2 2025 and has held it in 4 quarters since.
  • Caxton Associates (UK)'s Cardinal Health position peaked at $1.26M in Q4 2025.
  • 1,496 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.